EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Stenotrophomonas maltophilia infections – Biofilm-mediated virulence, multidrug resistance, clinical impact, and emerging treatment strategies: A review

Noha A Juma, Noura Daffa, Mona Alqarni, Bandar Hasan Saleh, Abdelbagi Alfadil, Tariq Ekhmimi, Jawahir A Mokhtar, Dalya Attallah, Khalil Alkuwaity, Sarah Almuhayya, Salem Agabawi, Turki Asiri und 7 weitere

Biomolecules and Biomedicine · 12.08.2026

DOI: 10.17305/bb.2026.14293 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules and Biomedicine, online erschienen am 12.08.2026. Verfasst von Noha A Juma und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Microbiology And Immunology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stenotrophomonas maltophilia is an opportunistic, multidrug-resistant (MDR), Gram-negative bacterium that has emerged as an important cause of hospital- and community-acquired infections, particularly in immunocompromised, critically ill, and hospitalized patients. Its increasing clinical relevance is driven by extensive virulence determinants, biofilm formation, intrinsic and acquired antimicrobial resistance, and persistence within healthcare-associated environmental reservoirs. This narrative review summarizes current evidence on the epidemiology, pathogenic mechanisms, antimicrobial resistance, and therapeutic management of S. maltophilia, with a particular focus on emerging treatment strategies. A literature search of PubMed, Scopus, Web of Science, and Google Scholar was performed to identify relevant studies published between 1997 and 2026. The available evidence demonstrates that biofilm formation, quorum sensing, adhesion factors, secretion of extracellular enzymes, and multiple resistance mechanisms—including β-lactamases, multidrug efflux pumps, and horizontally acquired resistance genes—substantially contribute to persistent infections and therapeutic failure. Hospital outbreaks are frequently associated with contaminated water systems, sinks, and medical devices, emphasizing the importance of environmental surveillance and infection control. Trimethoprim-sulfamethoxazole (TMP-SMX) remains the recommended first-line therapy, whereas minocycline, tigecycline, fluoroquinolones, and cefiderocol represent important alternatives for selected patients. Emerging approaches, including novel tetracyclines, bacteriophages, bacteriocins, ceragenins, anti-biofilm agents, and plant-derived compounds, have demonstrated promising preclinical activity against MDR and biofilm-associated infections, although robust clinical evidence remains limited. Continued surveillance, antimicrobial stewardship, pharmacokinetic/pharmacodynamic-guided therapy, and well-designed prospective clinical studies are essential to optimize the management of S. maltophilia infections and facilitate the translation of emerging therapeutic strategies into clinical practice.

Autor:innen und Institutionen

  • Department of Clinical Microbiology And Immunology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Department of Clinical Microbiology And Immunology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; Department of Clinical Microbiology Laboratory, King Abdulaziz University Hospital, Jeddah, Saudi…
  • Department of Clinical Microbiology Laboratory, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
  • EcoHealth Research Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia; Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jed…
  • Department of Clinical Laboratory Science, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.
  • Department of Internal Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.

Zitieren

APA

Juma, N. A., Daffa, N., Alqarni, M., Saleh, B. H., Alfadil, A., Ekhmimi, T., Mokhtar, J. A., Attallah, D., Alkuwaity, K., Almuhayya, S., Agabawi, S., Asiri, T., Allehebi, Z. O., Albar, M. H., Ahmed, K., Abu, I., Alharthi, T. M., Bukhari, A. G., & Ibrahem, K. (2026). Stenotrophomonas maltophilia infections – Biofilm-mediated virulence, multidrug resistance, clinical impact, and emerging treatment strategies: A review. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2026.14293

Vancouver

Juma NA, Daffa N, Alqarni M, Saleh BH, Alfadil A, Ekhmimi T, et al. Stenotrophomonas maltophilia infections – Biofilm-mediated virulence, multidrug resistance, clinical impact, and emerging treatment strategies: A review. Biomolecules and Biomedicine. 2026. doi:10.17305/bb.2026.14293

BibTeX
@article{Juma2026,
  author = {Juma, Noha A and Daffa, Noura and Alqarni, Mona and Saleh, Bandar Hasan and Alfadil, Abdelbagi and Ekhmimi, Tariq and Mokhtar, Jawahir A and Attallah, Dalya and Alkuwaity, Khalil and Almuhayya, Sarah and Agabawi, Salem and Asiri, Turki and Allehebi, Ziyad Omar and Albar, Mohammad Hassan and Ahmed, Khalid and Abu, Ibrahim and Alharthi, Turki M and Bukhari, Ahmed Gassim and Ibrahem, Karem},
  title = {Stenotrophomonas maltophilia infections – Biofilm-mediated virulence, multidrug resistance, clinical impact, and emerging treatment strategies: A review},
  journal = {Biomolecules and Biomedicine},
  year = {2026},
  doi = {10.17305/bb.2026.14293}
}
Kostenlos starten →